Streetbeat News

PCLOF

PharmaCielo Ltd.

Industry

All Other Miscellaneous Crop Farming

Open

0.06

Mkt cap

7.5M

Volume

500

High

0.06

P/E Ratio

-0.88

52-wk high

0.22

Low

0.05

Div yield

N/A

52-wk low

0.05

The cannabis industry saw significant leadership changes in 2023, with new CEOs appointed at various companies, including Humble & Fume Inc., WeedTube, MariMed, Unrivaled Brands, iAnthus Capital Holdings, PharmaCielo Ltd., MedMen Enterprises, Flora Growth Corp., Charlotte's Web, RX Green Technologies, AFC Gamma, Inc., Société québécoise du cannabis, The Blinc Group, and Kaival Brands Innovations Group. These changes are part of the industry's efforts to drive growth, sustainability, and social responsibility. Analysts are optimistic about the sector's potential for growth, with some stocks already showing substantial gains.

Portfolio Pulse from Jelena Martinovic

December 29, 2023 | 6:15 pm

Colombia's Senate has postponed the consideration of a bill to legalize marijuana, despite the measure having previously advanced through the Chamber of Representatives and a Senate committee. President Gustavo Petro criticized the Senate's decision, stating it would benefit illegal drug trade and increase violence. If the reform is to be pursued, the legislative process must restart next year. Cannabis companies like Clever Leaves Holdings Inc. (CLVR), PharmaCielo Ltd. (PCLOF), and Khiron Life Sciences Corp. (KHRNF) could benefit from such policy changes. The article also promotes Benzinga PotProfits, a service for cannabis stock investment opportunities.

Portfolio Pulse from Jelena Martinovic

December 15, 2023 | 1:21 pm

PharmaCielo Ltd. reported its Q3 2023 financial results, showing a narrowed net loss and reduced expenses compared to the previous year. Total revenue decreased, but selling, general, and administrative expenses were significantly lower, leading to a reduced net loss and adjusted EBITDA loss. CEO Marc Lustig highlighted the company's leaner organization and focus on higher margin products. PharmaCielo's shares dropped 6.8453% post-market on Tuesday. The company's assets and liabilities both increased compared to the end of the previous year.

Portfolio Pulse from Jelena Martinovic

November 29, 2023 | 2:44 pm

PharmaCielo Ltd. reported a significant drop in Q2 2023 revenue to $160,000 CAD from $2.1 million CAD in Q2 2022. The company also reported a net loss of $3.58 million CAD, slightly higher than the $3.51 million CAD loss in Q2 2022. Despite these results, CEO Marc Lustig remains optimistic about future growth, citing a 25% reduction in overhead expenses and steady sales progress. The company's shares traded 0.46% lower at $0.1195 per share.

Portfolio Pulse from Joana Scopel

August 29, 2023 | 8:20 pm

The article reports on recent leadership changes in the US cannabis industry. The Cannabis Regulators Association (CANNRA) has announced new leadership and expanded membership. Maryland Governor Wes Moore has made key appointments to two new cannabis-related agencies. Minnesota is preparing for marijuana legalization with the appointment of a new director for its regulatory agency. The Arkansas Medical Marijuana Commission has a new member. There have been board changes at Decibel Cannabis Company, High Tide Inc., Cresco Labs, Glass House Brands, and Craftport Cannabis Corp. Scotts Miracle-Gro Company has appointed a new board member. Unrivaled Brands, iAnthus Capital Holdings, PharmaCielo, and MedMen Enterprises have also made key appointments.

Portfolio Pulse from Jelena Martinovic

July 19, 2023 | 1:29 pm

PharmaCielo reports Q1 2023 revenue down 34.2% YoY, but CEO Bill Petron expects robust global sales of cannabis flower in 2023. The company has expanded its global business development organization and has made progress in markets such as Germany, the Czech Republic, Portugal, Poland, and Australia.

Portfolio Pulse from Maureen Meehan

May 29, 2023 | 12:48 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.